CGEM 8-K 2026-10-01

Cullinan Therapeutics, Inc. (CGEM) 8-K dated 2026-10-01 — accession 0001193125-26-411011. This URL is the filing, not the CGEM hub.

Cullinan Therapeutics, Inc. (CGEM) is a biotechnology company listed on US.

Cullinan Therapeutics, Inc. filed a 8-K on 2026-10-01. Accession 0001193125-26-411011.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $111.2M. CGEM currently screens at market cap $830.3M.

Not investment advice. The CGEM SEC hub lists recent forms. The stock page is the research view.